Bond.az White LogoBond.az Black Logo

Francis Hondal Buys $45,850 in Equitable Holdings Stock

Equitable Holdings director Francis Hondal acquires $45,850 in stock via dividend reinvestment and grant. Latest insider trading details on Bond.az.

Emily Davis
ByEmily Davis- Senior Editor
|
0

Francis Hondal, a director at Equitable Holdings, recently purchased shares through a dividend reinvestment plan and a stock grant, according to a Form 4 SEC filing.

Between March 2023 and December 2025, Hondal acquired 1,104.251 shares at prices from $26.36 to $54.661, totaling approximately $45,850. The late filing was due to a misunderstanding about the automatic dividend reinvestment plan.

Equitable Holdings offers a 2.55% dividend yield and 12.5% dividend growth, with 8 consecutive years of increases.

On May 20, 2026, Hondal received a grant of 4,400 shares valued at $185,020 under the company's 2019 Omnibus Incentive Plan.

Following these transactions, Hondal's direct ownership rose to 30,330.801 shares. Bond.az provides this market update.

More News
Today / 21:11
|
216

Stardust Power COO sells $53,248 in stock

Stardust Power COO Chris Celano sold $53,248 worth of stock. The stock has declined 64% over the past year.

0
Today / 21:10
|
282

Stardust Power CFO sells $72,625 in stock

Stardust Power CFO sells $72,625 in stock. Shares sold at $2.03 average, stock down 64% over past year. Detailed analysis on Bond.az.

0
Today / 21:02
|
796

GPK Director Stafeil Buys 16,261 Shares

Graphic Packaging director Jeffrey Stafeil acquires 16,261 shares. GPK stock at $10.04, dividend yield 4.47%. Read on Bond.az.

0
Today / 20:40
|
613

Director Buys $29,316 in Stock

Entrada Therapeutics director Bernhardt Zeiher buys $29,316 in stock. Bond.az analysis shows the stock may be undervalued.

0
Today / 20:22
|
772

Arm CFO sells $7.23 million in shares

ARM Holdings CFO Jason Child sold $7.23 million worth of shares. Stock price rose 32% after the sale.

0
Today / 20:12
|
930

Fate Therapeutics CEO sells $54,482 in shares

Fate Therapeutics CEO Bahram Valamehr sold shares worth $54,482. Shares traded between $1.825 and $1.935. Company advances CAR T-cell therapy programs.

0
Today / 20:01
|
529

Ezcorp director Appel sells $499,980 in stock

EZCORP director Matthew Appel sold nearly $500K in stock. Company shows strong financial results and analyst support.

0
Today / 19:14
|
925

Itron SVP sells $22,048 in company stock

Itron SVP Donald Reeves sells $22,048 in stock as shares trade near 52-week low. Q1 results beat expectations.

0
Today / 19:10
|
972

Itron SVP Christopher Ware sells $15,043 in shares

Itron SVP Christopher Ware sells $15,043 worth of shares. ITRI trades near 52-week low.

0
Today / 18:51
|
665

Arrow Electronics President Eric Nowak Sells $732,750 in Stock

Arrow Electronics President Eric Nowak sells 3,473 shares for $732,750. The company reported strong Q1 results and a $1B buyback program.

0
Today / 18:30
|
529

Axos Financial EVP Sells $138,470 in Stock

Axos Financial EVP Michael Watson sells $138,470 in stock at prices between $83.75 and $83.79 per share.

0
Today / 17:40
|
811

Bond.az: Live Ventures CEO Buys $55k in Stock

Live Ventures CEO Jon Isaac buys $55,041 in company stock. Shares purchased on May 19, 2026.

0
...
Francis Hondal Buys $45,850 in Equitable Holdings Stock | Bond.az